- Home
- CTRN vs RCKT Comparison
CTRN vs RCKT Comparison
Compare CTRN & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CTRN | RCKT |
|---|---|---|
| Founded | 1946 | 1999 |
| Country | United States | United States |
| Employees | N/A | 202 |
| Industry | Clothing/Shoe/Accessory Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 356.3M | 401.6M |
| IPO Year | 2005 | N/A |
Fundamental Metrics
Financial Performance| Metric | CTRN | RCKT |
|---|---|---|
| Price | $48.12 | $2.65 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 14 |
| Target Price | ★ $52.00 | $29.73 |
| AVG Volume (30 Days) | 123.2K | ★ 2.3M |
| Earning Date | 06-02-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 112.14 | N/A |
| EPS | ★ 0.91 | N/A |
| Revenue | ★ $819,962,000.00 | N/A |
| Revenue This Year | $8.81 | N/A |
| Revenue Next Year | $8.35 | $64.28 |
| P/E Ratio | $72.48 | ★ N/A |
| Revenue Growth | ★ 8.88 | N/A |
| 52 Week Low | $28.45 | $2.40 |
| 52 Week High | $56.78 | $5.45 |
Technical Indicators
Market Signals| Indicator | CTRN | RCKT |
|---|---|---|
| Relative Strength Index (RSI) | 56.62 | 31.31 |
| Support Level | $42.06 | N/A |
| Resistance Level | $48.59 | $3.42 |
| Average True Range (ATR) | 4.04 | 0.15 |
| MACD | 0.36 | -0.02 |
| Stochastic Oscillator | 60.85 | 21.26 |
Price Performance
Historical ComparisonAbout CTRN Citi Trends Inc.
Citi Trends Inc is a differentiated off-price value retailer known for trendy fashions, great brands and amazing prices. It is the off-price retailer specifically focused on Black customers, delivering the styles, brands, and trends at amazing prices that resonate with its primary and secondary customers. Its product offering is Women's, Men's and Children's apparel, family footwear, accessories and products for the home, with a three-tiered mix of product. At the opening price point, the company offers value-focused basics for its budget-conscious customers.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.